How collaboration can help counteract vaccine fatigue A program aimed at boosting COVID vaccination among vulnerable populations highlights the role of GP-led teams, writes Dr Ken McCroary.
Children’s version of COVID vaccination calculator released While vaccine coverage for 5–11-year-olds remains low, the updated CoRiCal tool could help boost uptake among the cohort.
Updating COVID-19 vaccines ‘on the agenda’, but not sustainable Many Australians were recently recommended a fifth dose – but vaccination fatigue has researchers looking for longer term solutions.
Second bivalent booster receives ATAGI recommendation The vaccine will become available in December and is recommended for people who have not had their first or second booster doses.
What do bivalent vaccines mean for Australia’s rollout? The first doses of Moderna’s variant-specific COVID vaccine became available this week, offering a slight advantage over previous versions.
TGA approves second COVID-19 vaccine for youngest children The Pfizer vaccine is now approved for use in children aged six months to five years, with Moderna already available to the age group.
Independent review into COVID vaccine procurement released Eight recommendations have been handed down, with the next two years identified as ‘critical’ to Australia’s recovery.
TGA approves vaccine booster for primary school age children Pfizer’s COVID-19 vaccine has been given the green light as a booster for children aged 5–11, with ATAGI recommendations to follow.
Vaccine rollout ‘relied on GP goodwill’: Study General practices involved in Australia’s COVID-19 vaccination program struggled to make ends meet, researchers say.
Vaccine rollout lessons put on hold An Audit Office report contains criticisms of planning and communication but offers few concrete suggestions for improvement.